Xu Kecheng, professor, chief physician, doctoral supervisor

　　Founder and president of Guangzhou Fuda Cancer Hospital, tumor treatment expert, chief expert of national key clinical specialty (oncology), president of Guangdong Light of Life Cancer Rehabilitation Association, founder of Guangdong Xu Kecheng Care Health Studio, lifetime honorary president of Jinan University Biomedical Translation Research Institute and president of Hydrogen Medical Research Institute, and second vice president of Guangdong Clinical Medicine Association. In 2012, he won the highest honor of China's health system, the "Bethune Medal", and in 2014 he was awarded the title of China's "Model of the Times" and a nominee for the National Moral Model. Honorary President of the International Cryosurgery Society, legal person and honorary president of the Asian Cryosurgery Society. He has won many awards in the field of international cryosurgery and was praised as an "outstanding contributor to world cryosurgery technology" by the Geneva WHO Forum.

　　Engaged in clinical and research on liver cancer and pancreatic cancer, and edited the first pancreatic disease monograph in China, "Clinical Pancreatology". He has achieved outstanding results in tumor cryotherapy, vascular interventional therapy and combined immunotherapy, and created the "3C+P" model for the treatment of advanced cancer. He has edited 9 monographs, including the first "Tumor Cryotherapy" in China and the first Modern Cryosurgery for Cancer in the world, as well as the first "New Technology for Tumor Ablation: Irreversible Electroporation" in China; he has published more than 500 papers, including more than 100 SCI papers on tumor ablation and immunotherapy.

　　Voice:

　　As a doctor, I hope to provide patients with the most appropriate "smart treatment". As a cancer patient and survivor, I hope our doctors can provide our patients with the most appropriate and least painful treatment. As a warrior challenging cancer, I feel honored. I believe that humans will eventually defeat cancer, and our cancer patients will be able to recover or coexist with cancer for a long time.